Antares Says Partner Teva First to File for Generic Version of Lilly's Forteo

Wednesday, Apr 06, 2016

Antares Pharma Inc "pen 1" development project with teva pharmaceutical relates to a generic form of forteo marketed by eli lilly.

Believes that teva may be "first applicant" to file an anda for a generic equivalent of forteo.

Believes should teva's anda be approved, may be entitled to 180 days of generic market exclusivity.


Source :

Other News